Sensitivities of benzodiazepine receptor binding and muscarinic acetylcholine receptor binding for the detection of neural cell death caused by sodium nitroprusside microinjection in rat brain

Synapse

Volumn 49, Issue 2, 2003, Pages 134-141

  Inoue, Osamu ^a,c   Yanamoto, Kazuhiko ^a   Fujiwara, Yoshiko ^a   Hosoi, Rie ^a   Kobayashi, Kaoru ^a   Tsukada, Hideo ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Benzodiazepine receptor; Brain; Muscarinic acetylcholine receptor; Neural cell death; Sodium nitroprusside (SNP)

Indexed keywords

1 METHYL 4 PIPERIDYL BENZILATE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; BENZODIAZEPINE RECEPTOR; DEFEROXAMINE; FLUMAZENIL; IRON CHELATING AGENT; LINSIDOMINE; MUSCARINIC RECEPTOR; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; RADIOLIGAND; TRIPHENYLTETRAZOLIUM; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; INTERMETHOD COMPARISON; IRON CHELATION; LIGAND BINDING; MALE; MICROINJECTION; NERVE CELL NECROSIS; NEUROPROTECTION; NISSL STAINING; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; STAINING; STATISTICAL SIGNIFICANCE;

ANIMALS; BRAIN; CELL DEATH; MALE; MICROINJECTIONS; NEURONS; NITROPRUSSIDE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, MUSCARINIC;

EID: 0038807900     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10217     Document Type: Article

References (37)

1. Albers DS, Beal MF. 2000. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 59:133-154.
2. 1 binding sites in gerbil brain. Protective effects of a novel vinca alkaloid derivative, vinconate, and pentobarbital using an autoradiographic study. Res Exp Med (Berl) 192:79-88.
3. Asahina M, Suhara T, Shinotoh H, Inoue O, Suzuki K, Hattori T. 1998. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study. J Neurol Neurosurg Psychiatry 65:155-163.
4. Baron JC. 2001. Mapping the ischemic penumbra with PET: a new approach. Brain 124:2-4.
5. Bates JN, Baker MT, Guerra Jr R, Harrison DG. 1991. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 42(Suppl):S157-S165.
6. Boullerne AI, Nedelkoska L, Benjamins JA. 1999. Synergism of nitric oxide and iron in killing the transformed murine oligodendrocyte cell line N20.1. J Neurochem 72:1050-1060.
7. Buck A, Mulholland GK, Papadopoulos SM, Koeppe RA, Frey KA. 1996. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection. J Cereb Blood Flow Metab 16:1280-1287.
8. Chen J, Chang B, Williams M, Murad F. 1991. Sodium nitroprusside degenerates cultured rat striatal neurons. Neuroreport 2:121-123.
9. Dong Y, Fukuyama H, Nabatame H, Yamauchi H, Shibasaki H, Yonekura Y. 1997. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study. Stroke 28:1776-1782.
10. Heiss WD. 2001. Imaging the ischemic penumbra and treatment effects by PET. Keio J Med 50:249-256.
11. Heiss WD, Graf R, Fujita T, Ohta K, Bauer B, Lottgen J, Wienhard K. 1997. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 28:2045-2052.
12. Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, Bauer B, Wienfard K. 1998. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 29:454-461.
13. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 31:366-369.
14. Heiss WD, Graf R, Wienhard K. 2001a. Relevance of experimental ischemia in cats for stroke management: a comparative reevaluation. Cerebrovasc Dis 11:73-81.
15. Heiss WD, Kracht LW, Thiel A, Grond M, Pawlik G. 2001b. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischemia. Brain 124:20-29.
16. Hironishi M, Ueyama E, Senba E. 1999. Systemic expression of immediate early genes and intensive astrocyte activation induced by intrastriatal ferrous iron injection. Brain Res 828:145-153.
17. 3H-QNB in mouse brain. J Neural Transm 106:583-592.
18. Lewen A, Matz P, Chan PH. 2000. Free radical pathway in CNS injury. J Neurotrauma 17:871-890.
19. Love S. 1999. Oxidative stress in brain ischemia. Brain Pathol 9:119-131.
20. Markesbery WR, Carney JM. 1999. Oxidative alterations in Alzheimer's disease. Brain Pathol 9:133-146.
21. 99mTc-HMPAO in experimental brain ischemia. Nucl Med Commun 16:581-590.
22. Mizuno A, Umemura K, Nakashima M. 1998. Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. Gen Pharmacol 30:575-578.
23. Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, Fukuchi K, Hori M, Nishimura T. 1998. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med 39:1348-1353.
24. 11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nucl Med Biol 22:13-17.
25. Nakagawara J, Sperling B, Lassen NA. 1997. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke 28:124-132.
26. Nakashima M, Niwa M, Iwai T, Umematsu T. 1999. Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat. Free Radic Biol Med 26:722-729.
27. 11C]methyl-4piperidyl benzilate in the conscious monkey brain. Nucl Med Biol 27:733-740.
28. O'Neill M, Canney M, Earley B, Junien JL, Leonard BE. 1996. The novel sigma ligand JO 1994 protects against ischemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil. Neurochem Int 28:193-207.
29. Onodera H, Sato G, Kogure K. 1987. GABA and benzodiazepine receptors in the gerbil brain after transient ischemia: demonstration by quantitative receptor autoradiography. J Cereb Blood Flow Metab 7:82-88.
30. Ouchi Y, Tsukada H, Kakiuchi T, Nishiyama S, Futatsubashi M. 1998. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med 39:198-202.
31. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th ed. San Diego: Academic Press.
32. A receptor-gated ion channel: biochemical and pharmacological studies of structure and function. Biochem Pharmacol 37:3369-3375.
33. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barre L, Travere JM, Derlon JM, MacKenzie ET. 1993. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 24:20462058.
34. Toulmond S, Serrano A, Benavides J, Scatton B. 1993. Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window. Brain Res 620:32-41.
35. Yamada M, Momose K, Richelson E, Yamada M. 1996. Sodium nitroprusside-induced apoptotic cellular death via production of hydrogen peroxide in murine neuroblastoma N1E-115 cells. J Pharmacol Toxicol Methods 35:11-17.
36. Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito KI, Kogure K, 1997. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 762:240-242.
37. 11C]NMPB and PET. Synapse 39:275-287.